BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Head and neck cancer AND ERCC5, XPGC, 2073, ENSG00000134899, RP11-484I6_5, COFS3, XPG, UVDR, ERCM2 AND Treatment
33932 results:

  • 1. Variation of resection margins in oral cancer in dependence of tumor stage and subsite - a retrospective cohort study.
    Moratin J; Horn D; Oehme M; Semmelmayer K; Flechtenmacher C; Ristow O; Held T; Engel M; Hoffmann J; Freudlsperger C
    Clin Oral Investig; 2024 May; 28(6):327. PubMed ID: 38764079
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Immunotherapy combined with apatinib in the treatment of advanced or metastatic gastric/gastroesophageal tumors: a systematic review and meta-analysis.
    Wang J; Lin J; Wang R; Tong T; Zhao Y
    BMC Cancer; 2024 May; 24(1):603. PubMed ID: 38760737
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Palliative treatment of generalized metastatic follicular carcinoma of thyroid after operation: A case report and literature review.
    Zhao H; Kang W; Guan J; Wang Y
    Medicine (Baltimore); 2024 May; 103(20):e38237. PubMed ID: 38758843
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Robotic and endoscopic trans-oral total laryngectomy, a systematic review and meta-analysis.
    Tumlin P; Dugan B; Hassid S; Lawson G; Turner M
    J Robot Surg; 2024 May; 18(1):214. PubMed ID: 38758418
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Erythema dyschromicum perstans-like eruptions induced by epidermal growth factor receptor inhibitors in patients with lung cancer.
    Bang AS; Said JT; Hirner J; Rana J; Pugliese S; Wang JY; Zaba L; Zhao L; Doan L; Smith J; Kwong BY
    Support Care Cancer; 2024 May; 32(6):354. PubMed ID: 38750379
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Downregulation of KLF5 by EBER1 via the ERK signaling pathway in EBV-positive nasopharyngeal carcinoma cells: implications for latent EBV infection.
    Hu J; Xin F; Liu W; Gong Z; Zhang Y; Liu S
    J Gen Virol; 2024 May; 105(5):. PubMed ID: 38747699
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Interventional radiotherapy (brachytherapy) for re-irradiation of recurrent head and neck malignancies: oncologic outcomes and morbidity.
    Bussu F; Fionda B; Rigante M; Rizzo D; Loperfido A; Gallus R; De Luca LM; Corbisiero MF; Lancellotta V; Tondo A; D'Aviero A; Mattiucci GC; Kovacs G; Galli J; Tagliaferri L
    Acta Otorhinolaryngol Ital; 2024 May; 44(Suppl. 1):S28-S36. PubMed ID: 38745514
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Long-term prognosis after endoscopic submucosal dissection for esophageal cancer in older adult patients.
    Konishi H; Urabe Y; Nakamura T; Ishibashi K; Mizuno J; Fukuhara M; Takasago T; Tanaka H; Tsuboi A; Yamashita K; Hiyama Y; Takigawa H; Kotachi T; Yuge R; Ishikawa A; Oka S
    BMC Gastroenterol; 2024 May; 24(1):164. PubMed ID: 38745162
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Nutritional responsiveness affects novel neutrophil parameters and reduces in-hospital mortality and costs in elective cancer oesophagectomy - a single centre, prospective, observational study.
    Kutnik P; Borys M; Nurczyk K; Domerecka W; Dziedzic J; Buszewicz G; TeresiƄski G; Donica H; Piwowarczyk P; Czuczwar M
    Anaesthesiol Intensive Ther; 2024; 56(1):77-82. PubMed ID: 38741447
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Evaluation of Platelet Parameters in Oral Submucous Fibrosis and Oral Squamous Cell Carcinoma in a Background of Oral Submucous Fibrosis.
    Ranjitham PS; Kuzhali S; Sumathy MP; Gnandeepam S
    Indian J Dent Res; 2023 Oct; 34(4):417-421. PubMed ID: 38739824
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Triglyceride-inflammation score established on account of random survival forest for predicting survival in patients with nasopharyngeal carcinoma: a retrospective study.
    Li J; Ye Y; Cai Y; Ji H; Qin W; Luo Y; Zhou X; Zhang Z; Xiao X; Zhang B
    Front Immunol; 2024; 15():1375931. PubMed ID: 38736892
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. A nomogram based on nutritional and inflammatory parameters to predict DMFS and identify beneficiaries of adjuvant chemotherapy in IVA-stage nasopharyngeal carcinoma.
    Pan Y; Chen Z; Hong W; Huang Z; Li Y; Cai S; Lai J; Lu J; Qiu S
    BMC Cancer; 2024 May; 24(1):578. PubMed ID: 38734620
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. High incidence of lung cancer death after curative endoscopic submucosal dissection for superficial esophageal squamous cell carcinoma.
    Tajiri A; Tsujii Y; Nishida T; Inoue T; Maekawa A; Kitamura S; Yamaguchi S; Nishihara A; Yamada T; Ogiyama H; Murayama Y; Yamamoto S; Egawa S; Uema R; Yoshihara T; Hayashi Y; Takehara T
    Cancer Med; 2024 May; 13(9):e7242. PubMed ID: 38733176
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Outcomes of patients in nasopharyngeal adenoid cystic carcinoma in the IMRT era: a single-center experience.
    Wu WB; Cai WL; Zou YH; You R; Liu YP; Yuan ZD; Li Q; Li WC; Pi ZX; Xie YL; Wen K; Chen MY; Sun R
    BMC Cancer; 2024 May; 24(1):576. PubMed ID: 38730348
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. To develop a prognostic model for neoadjuvant immunochemotherapy efficacy in esophageal squamous cell carcinoma by analyzing the immune microenvironment.
    Yehan Z; Sheng Q; Hong Y; Jiayu L; Jun H; Juan J; Min S; Jiaxin Y; Shangzhi H; Yi W; Qifeng W; Xuefeng L; Wenwu H; Xueyan C; Yang L; Zongyao H
    Front Immunol; 2024; 15():1312380. PubMed ID: 38726002
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. A Competing Risk Nomogram for Prediction of Prognosis in Patients With Primary Squamous Cell Thyroid Carcinoma.
    Tian Y; He L; Zhang B; Deng L; Wang J
    Technol Cancer Res Treat; 2024; 23():15330338241254059. PubMed ID: 38725285
    [No Abstract]    [Full Text] [Related]  

  • 17. Pathological response to neoadjuvant chemoradiotherapy for oesophageal squamous cell carcinoma in Eastern versus Western countries: meta-analysis.
    Gao X; Overtoom HCG; Eyck BM; Huang SH; Nieboer D; van der Sluis PC; Lagarde SM; Wijnhoven BPL; Chao YK; van Lanschot JJB
    Br J Surg; 2024 May; 111(5):. PubMed ID: 38721902
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Addition of tumor microenvironment immune cell composition to improve the performance of a predictive model for oral squamous cell carcinoma.
    Bisheshar SK; van der Kamp MF; de Vries J; Slagter-Menkema L; Schuuring EMD; Lunter GA; Halmos GB; van der Vegt B
    Oral Oncol; 2024 Jun; 153():106830. PubMed ID: 38718459
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Establishing subdivisions of M1 stage nasopharyngeal carcinoma based on decision tree classification: A multicenter retrospective study.
    Liu Y; Zuo ZC; Zeng XY; Ma J; Ma CX; Chen RZ; Liang ZG; Chen KH; Li L; Qu S; Lu JY; Zhu XD
    Oral Oncol; 2024 Jun; 153():106834. PubMed ID: 38718458
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Enhanced MRI Radiomics Based Model for Predicting Recurrence or Metastasis of Nasopharyngeal cancer (NC) Undergoing Concurrent Chemoradiotherapy: A Retrospective Study.
    Song L; Liu J; Shang Y; Hu Y; Zhang J; Ye Y; Ji X; An P
    Cancer Control; 2024; 31():10732748241250208. PubMed ID: 38716756
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 1697.